Related Experiment Video
Updated: Jun 23, 2026
09:19
Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization
Published on: March 16, 2020
X-ray structure breakthroughs in the GPCR transmembrane region.
1Department of Computational Chemistry, Lundbeck Research USA, Inc., 215 College Road, Paramus, NJ 07652, USA.
Biochemical Pharmacology
|May 19, 2009
Summary
G-protein-coupled receptors (GPCRs) are crucial drug targets. Recent X-ray structures of class A GPCRs offer improved templates for structure-based drug design, overcoming limitations of previous models like rhodopsin.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- G-protein-coupled receptors (GPCRs) represent the largest class of drug targets, accounting for 25-50% of marketed pharmaceuticals.
- GPCRs share a common structure featuring seven transmembrane alpha-helices, making them attractive for structure-based drug design.
- Historically, modeling GPCRs relied on bovine rhodopsin, a Class A GPCR, but its distant homology and lack of ligand activation introduced significant uncertainty.
Purpose of the Study:
- To review recent advancements in obtaining X-ray structures for Class A GPCRs.
- To explore the implications of these new structures for understanding GPCR mechanisms and facilitating structure-based drug design.
- To provide perspective on emerging opportunities, limitations, and future research directions in GPCR structural biology.
Main Methods:
- Analysis of recent publications detailing X-ray crystal structures of Class A GPCRs.
- Comparative assessment of new GPCR structures against the limitations of using bovine rhodopsin as a template.
- Literature review to synthesize findings on GPCR structural insights and their application in drug discovery.
Main Results:
- Recent X-ray structures of ligand-activated Class A GPCRs provide more accurate templates for homology modeling.
- These structures enable a deeper understanding of molecular mechanisms at the atomic level.
- Direct deployment of these structures for structure-based design is now feasible, improving drug discovery efforts.
Conclusions:
- New X-ray structures of Class A GPCRs significantly enhance the potential for structure-based drug design.
- These structural insights offer more reliable templates for developing therapeutics targeting a wide range of GPCRs.
- Further research is needed to fully exploit these opportunities and address remaining challenges in GPCR drug discovery.
Related Concept Videos
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:09Multi-pass Transmembrane Proteins and β-barrels
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...